(Am J Cmliol1~72:16+170) P ercutaneous transluminaJ coronary balloon angioplasty is now widely accepted as a safe and effective treatment in selected patients with obstructive coronary artery disease.' However, acute vessel closure and late restenosis are inherent to balloon angioplasty and continue to compromise its efficacy.2,3 Although the exact pathophysiologic mechanism(s) and factors responsible for restenosis are largely unknown, some clinical and angiographic variables have been identified as potential risk factors.4 There is, furthermore, some evidence that repeat angioplasty of a previously dilated lesion in a native coronary artery is associated with a higher incidence of restenosiss9 The Wiktor stent has been used to treat such patients. The incidence of recurrence of restenosis following Wiktor stent implantation in the first 50 consecutive patients has recently been published.tO The purpose of this study was to try to identify angiographic predictors of recurrence of restenosis after Wiktor stent implantation. This may not only have important clinical consequences, but may also broaden our understanding of the pathophysiology of restenosis.
MRHODS
PatienW Between January 1990 and May 1992, Wiktor stent implantation was attempted in 193 patients because of recurrence of angina due to restenosis of a native coronary artery lesion after previous balloon angioplasty. The study population consisted of 91 of the 109 consecutive patients with successful stent implantation without clinical evidence of thrombotic stent occlusion during hospital stay and in whom the scheduled follow-up angiography was completed at 5.7 Ifr 1.9 months (mean + SD) (Figure 1) .
Eighty-one patients were men (89%); the mean age (& SD) was 58 f 11 years. A first restenosis was documented in 50 patients (55%), a second in 32 patients vessel size. In addition to these continuous variables, one discrete variable (left anterior descending artery) was selected. All coronary angiograms were analyzed with the computer-assisted Cardiovascular Angiography Analysis System. Its principles and deft&ions of angiographic variables has been described in a previous study on Wiktor stent implantation.11 Since the primary objective of this study was to identify angiographic variables predicting restenosis, the process of restenosis was dichotomized and delined according to the 0.72 mm and 50% diameter stenosis criteria. 17 staU&ks A relative risk analysis was performed for the aforementioned angiographic variables. To avoid an arbitrary subdivision of data in the continuous variables, the median value was chosen as cutoff point. The selection of this value as cutoff point has the advantage of being consistent for all values, and thus avoids any bias in the selection of subgroups that might be undertaken to emphasize a particular point. All values are expressed as mean f SD. The risk for restenosis for each parameter according to the 0.72 mm and 50% diameter stenosis criteria was determined by using an univariate analysis and is expressed as odds ratio with corresponding 95% confidence interval. An odds ratio of 1.0 for a particular variable implies that the presence of that variable poses no additional risk for restenosis, an odds ratio >l.O or cl.0 implies additional or reduction in risk. Furthermore, since experimental animal data indicate that there is a relation between the severity of vessel wall injury and the extent of subsequent neointimal thickening, the relation between relative gain (as index of vessel wall injury) and relative loss (as index of neointimal thickening) was studied using a regression analysis. The relative gain is previously defined. The relative loss is the difference between the minimal luminal diameter immediately after stent implantation and at follow-up normalized to the vessel size.
RESULTS
hcidmce d restamh The changes in stenosis geometry are summarized in Table I . The incidence of restenosis was 44% (40 of 91 patients) according to the 0.72 mm criterion and 30% (27 of 91 patients) according to the 50% diameter stenosis criterion. When the stent is used as a unit, the incidence of restenosis was 45% (41 of the 92 stents) and 29% (27 of the 92 sterns), respectively ( Figure 2) . WC predictors: The relative risk and 95% confidence intervals for each variable using either of the sequent restenosis after stenting. The odds for restenosis in case of stent implantation for a second, third or fourth restenosis compared with stent implantation for a lirst restenosis was 0.8 (95% contidence interval 0.4-1.8) according to the 0.72 mm criterion and was 1.5 (95% cotidence 0.6-3.7) according to the 50% diameter stenosis criterion.
Regression analysis: The relation between relative gain, as index of vessel wall injury, and relative loss, as index of late neointimal hyperplasia as vessel wall response to injury, is shown in Figure 3 . A Pearson product-moment correlation coefficient of 0.38 was found (p <O.OOl, slope 0.61, intercept -0.06).
DISCUSSION
The primary objective of this study was not the determination of the incidence of recurrent restenosis after Wiktor stent implantation in patients with restenosis after previous balloon angioplasty. However, it is noteworthy that the incidence of poststent restenosis reported here in the 91 patients is identical to the incidence of recurrent restenosis in the tist 50 consecutive patients.'O Detailed analysis of a subgroup of 74 patients revealed that there was no late compression of the stent itself. Therefore, late loss or restenosis was due to ingrowth of tissue into the lumen of the stented segment.t8
The lack of randomized studies precludes any conclusion as to whether stent implantation in this subset of patients will reduce the incidence of subsequent restenosis. Moreover, the exact incidence of recurrent restenosis after repeat balloon angioplasty is not known. There is some evidence that it increases with the number of repeat angioplasties. A second restenosis has been reported to occur in 25 and 34%, but amounts to 39 and 40% after a third or fourth angioplasty, respectively.~9 These data should be interpreted with caution considering the difference between the study populations, the difference in definition of restenosis, and in the time and completeness of follow-up angiography. In the present study in which stems were implanted because of restenosis, the risk for recurrent restenosis alter stenting did not differ between patients with a first restenosis and patients with a second, third or fourth restenosis. Two other studies failed to show a statistically sign&ant difference in the restenosis rate for primary or de novo lesions compared with lesions that had undergone previous balloon angioplasty. 12,13 However, subgroup analysis of patients in whom a single Palmaz-Schatz stent was implanted showed a restenosis rate of 13% compared with 36% for patients with previous restenosis.*3 -0. The development of restenosis remains incompletely understood. Histologic data have shown that any injury to the vessel wall, whatever its nature, will invariably be associated with neointimal hyperplasia as a nonspecilic tissue response leading to restenosis when excessive.14J9-23 It is of both scientitic and utmost clinical importance to know and understand its development and to know the factors controlling the extent of the vessel wall response following injury. Experimental animal studies, postmortem pathologic observations in humans and angiographic studies have shown that the extent of neointimal hyperplasia is proportional to the degree of injury applied to the vessel wall (Figure 4 ).t4-16J4 This is in accord with earlier work in the porcine model, describing a relation between the degree of injury and early platelet deposition.25~26 In the present study, the relative gain was used as angiographic correlate of vessel wall injury. This parameter was found to be the only statisticahy signilicant predictor of recurrence of restenosis when using the 0.72 mm criterion. The drawback of the . _._ ApesRivelhemmlatienwasfeundwRha~cadi fhnt(R)ofO.SS@eO.OO2)wRhadopeof0.6OtmnJan
latter is, lirst, that the process of restenosis is dichotilMNqRof9~.
omized (present/not present) and second, that although statistically justifiable, cutoff points are used for the angiogmphic variables under investigation. However, the continuous approach underscores these Iindings by indicating a positive linear relation between the relative gain and relative loss. These observations were still valid when using absolute measurements. However, the correlation between the absolute gain and absolute loss was somewhat weaker (r = 0.21, p = 0.05). This is explained by the fact that the use of absolute values does not relate these changes to the vessel size. Although we found no difference in absolute loss between small and large vessels, an identical loss in minimal luminal diameter represents a larger relative loss in a small vessel than in a large vessel, and vice versa. This conlirms other studies using a categorical approach to detine restenosis after stenting, that small vessels are not, per se, more prone to restenosis than large vessels.12J3,27 This concept, describing a proportional relation between vessel wall injury and neointimal thickening, has been reported in other studies using quantitative coronary angiography. Beatt et ali6 found that restenosis (0.72 mm criterion) was signilicantly correlated with both a greater improvement in obstruction diameter and a larger absolute dimension aher balloon angioplasty. Furthermore, in a recent study,28 the absolute change in minimal luminal diameter was reported to be the greatest single determinant of late luminal narrowing after balloon angioplasty. In another rep~rt?~ it was found that interventions achieving a "bigger" lumen provoke a concomitantly larger relative loss, so that the ultimate end point of various treatment methods is similar.
All these findings carry potential far-reaching clinical implications. Clearly the greater the improvement in minimal luminal diameter achieved by intervention, the greater the magnitude of subsequent luminal narrowing will be. Unfortunately, what cannot be extrapolated from the data is how much damage the clinician may intlict on the vessel wall. On the one hand, a suboptimal angiographic result is associated with a higher risk of subacute occlusion due to rheologic factors and platelet deposition and a higher need for repeat balloon angioplasty but, on the other hand, improvement of the initial result may be at the price of more extensive late neointimal thickening.i4i6*30,31 This indistinctness can be circumvented by properly matching the balloon size or device with the vessel wall using on-line quantitative coronary angiography. This is underscored by the data displayed in Figure 5 indicating that the more the stent is oversized, the greater the loss in minimal luminal diameter will be.
So far, there are 2 other angiographic studies that have attempted to identify risk factors for restenosis or recurrence of restenosis, and they found, as in the present study, that the vessel size and severity of stenosis, expressed as diameter stenosis and length of the lesion, not to be associated with an increased risk for restenosis.r2J3 As mentioned, the indication (primary or secondary stenting) was not associated with an increased risk for restenosis.12J3 In accordance with these 2 studies on stenting and 1 other study on balloon angioplasty, the target vessel was not associated with an increased risk for (recurrent) restenosis.12J3.32 SW limitations: The study limitations are essentially twofold. First, the precision of relative gain as an angiographic index of vessel wall injury and relative loss as an index of neointimal hyperplasia has not been studied. The coronary angiogram is a 2dirnensional echocardiogram describing the changes in stenosis geometry but not the nature or extent of the pathology explaining these angiographic changes. Therefore, the measurement of the minimal luminal diameter, and consequently the relative gain and loss, are subject to potential imprecision. Second, the effect of other clinical, procedural and lesion-related characteristics on the development of late neointimal hyperplasia has not been considered. It is conceivable that if these characteristics play a role in the pathogenesis of neointimal thickening, they may not be uniformly distributed over the study population.
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